Page History

...

The purpose of the TIG is to guide the use of CDISC standards for the organization, structure, and format of

...

tobacco product data submitted to a regulatory authority.

...

The TIG Version 1.0 provides specific domain models, assumptions, business rules, and examples for preparing standard data collection, tabulation datasets, and analysis datasets that are based on the CDASH, SDTM, ADaM, and Analysis Results models respectively. This document is intended for companies and individuals involved in the collection, preparation, and analysis of product description, non-clinical, and clinical data that will be submitted to regulatory authorities. The TIG should be used in close concert with:provides guidance for the

• collection of study data with case report forms (CRFs) using the Version 1.2 of the CDISC Clinical Data Acquisition Standards Harmonization (CDASH, available at https://www.cdisc.org/standards/foundational/cdash/cdash-model-v1-2) , provides a general framework for creating fields to collect information on CRFs and includes the model metadata, which shows the standard variables in the model.Version 2.0 of the CDISC
• tabulation of study data using the Study Data Tabulation Model (SDTM, available at https://www.cdisc.org/standards/foundational/sdtm), which describes the general conceptual model for representing clinical study data that is submitted to regulatory authorities.), and
• creation of analysis datasets using the Version 2.1 of the CDISC Analysis Data Model (ADaM, avalible at ), which describes...
• Version TBD of the Analysis Results Model... 
• Version 2.0 ODM-XML
• Version 1.0 Lab-XML
• Version 2.1 Define-XML...

The Therapeutic Area Data Standards Modules for Type 1 Diabetes - Screening, Staging, and Monitoring for Preclinical Type 1 Diabetes were developed with support from The Leona M. and Harry B. Helmsley Charitable Trust using the CDISC standards development process. This process included collecting input from various stakeholders to ensure the standard is as thorough as possible. A number of volunteers and experts provided resources and input to support the development of this standard. The goal of this initiative is to identify a core set of clinical therapeutic area concepts and endpoints for targeted therapeutic areas and translate them into CDISC standards to improve semantic understanding, support data sharing, and facilitate global regulatory submission. As with all CDISC therapeutic area standards, the purpose of this standard is to describe how to use CDISC standards to represent data pertaining to a targeted therapeutic area—in this case, screening, staging, and monitoring for preclinical type 1 diabetes (T1D). "Preclinical" refers to the time before stage 3 (clinical diagnosis) of T1D.

This first provisional version (v1.0 Provisional) of the standard focuses on T1D clinical trials involving screening, staging, and monitoring for preclinical T1D.

This document provides advice and examples for Clinical Data Acquisition Standards Harmonization (CDASH) and the Study Data Tabulation Model (SDTM), including

• guidance on the use of domains and variables;

• sample annotated case report forms (aCRFs); and

• examples of SDTM datasets, with text describing the situational context and pointing out records of note.

...

• with
• references to additional CDISC standards and resources to support implementation.

The TIG also provides examples for use cases inherent to tobacco product studies to demonstrate and support understanding of the intended use of standards.